Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis

2 Jul 2024

Abstract excerpt

BACKGROUND: Evidence has revealed a connection between cuproptosis and the inhibition of tumor angiogenesis. While the efficacy of a model based on cuproptosis-related genes (CRGs) in predicting the prognosis of peripheral organ tumors has been demonstrated, the impact of CRGs on the prognosis and the immunological landscape of gliomas remains unexplored. METHODS: We screened CRGs to construct a novel scoring...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38956740
DOI: 10.1186/s40246-024-00636-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysisPMID 38956740Read ↗

A prognostic cuproptosis gene signature predicts immune function and chemotherapy response in gliomasSemantic proximity Read ↗

Cuproptosis-related Gene Slc31a1 Expression Correlates With the Prognosis and Tumor Immune Microenvironment in GliomaSemantic proximity Read ↗

Cuprotosis clusters predict prognosis and immunotherapy response in low-grade gliomaSemantic proximity Read ↗

Construction and validation of a cuproptosis-related prognostic model for glioblastomaSemantic proximity Read ↗

Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in gliomaSemantic proximity Read ↗

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.Semantic proximity Read ↗

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastomaSemantic proximity Read ↗

Cuprotosis Clusters Predicts Prognosis and Immunotherapy Response in Low-grade gliomaSemantic proximity Read ↗

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomasSemantic proximity Read ↗

Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastomaSemantic proximity Read ↗

Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypesSemantic proximity Read ↗

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.